S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance (2015/2/10)|
|Charles River Laboratories Announces Planned Management Changes (2015/2/24)|
|Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (2015/1/12)|
|Charles River Laboratories to Present at Leerink Global Healthcare Conference (2015/2/11)|
|Charles River Laboratories Schedules Fourth-Quarter 2014 Earnings and 2015 Guidance Release and Conference Call (2015/1/26)|
|POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA (2014/12/17)|
|SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. - POZN (2014/12/17)|
|AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso (2014/12/2)|
|AcelRx Pharmaceuticals to Present at BIO CEO & Investor Conference (2015/2/4)|
|EQUITY UPDATE: Rosen Law Firm Expands Class Period in Aeterna Zentaris, Inc. Investor Class Action to Include Purchasers Between April 2, 2012 and November 6, 2014 - AEZS (2015/1/6)|
Click above to view more mutual fund data and stats for crl - Charles River Laboratories International Inc.